Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precision Biosciences Inc (DTIL)

Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Precision Biosciences Inc 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 USA

www.precisionbiosciences.com Employees: 68 P: 919-314-5512 F: 480-393-5553

Sector:

Medical

Description:

Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.

Key Statistics

Overview:

Market Capitalization, $K 134,020
Enterprise Value, $K 45,600
Shares Outstanding, K 24,727
Float, K 23,738
% Float 96.00%
Short Interest, K 1,397
Short Float 5.65%
Days to Cover 4.96
Short Volume Ratio 0.16
% of Insider Shareholders 4.00%
% of Institutional Shareholders 37.99%

Financials:

Annual Sales, $ 34,260 K
Annual Net Income, $ -45,720 K
Last Quarter Sales, $ 34,200 K
Last Quarter Net Income, $ 20,130 K
EBIT, $ -52,150 K
EBITDA, $ -50,080 K

Growth:

1-Year Return 15.32%
3-Year Return -77.13%
5-Year Return -97.90%
5-Year Revenue Growth 41.05%
5-Year Earnings Growth 92.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.36 on 03/12/26
Next Earnings Date 05/21/26
Earnings Per Share ttm -5.82
EPS Growth vs. Prev Qtr 119.57%
EPS Growth vs. Prev Year 111.25%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 02/14/24

DTIL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -122.60%
Return-on-Assets % -48.98%
Profit Margin % -133.45%
Debt/Equity 0.24
Price/Sales 4.34
Price/Cash Flow N/A
Price/Book 1.62
Book Value/Share 4.03
Interest Coverage -31.82
60-Month Beta 1.28
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.